News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Vrouyr Bilemjian: Excellent talks by leading pharma and biotech companies at BioTechX Europe
Vrouyr Bilemjian/LinkedIn
Nov 2, 2024, 20:09

Vrouyr Bilemjian: Excellent talks by leading pharma and biotech companies at BioTechX Europe

Vrouyr Bilemjian, Strategy Consultant at Innoplexus, shared a post on LinkedIn:

“Had a great time at BioTechX Europe in Basel, Switzerland, one of the leading AI conferences dedicated to biopharma industry, representing Partex and discussing with partners how we support them in drug discovery, development, and asset in/out licensing through our proprietary AI models and solutions.

I also attended some excellent talks by leading pharma and biotech companies on implementing AI and GenAI in R&D, manufacturing, and daily operations, as well as recent innovations in the field.

Already looking forward to next year’s summit and glad to be part of this innovative ecosystem.”

Vrouyr Bilemjian: Excellent talks by leading pharma and biotech companies at BioTechX Europe Vrouyr Bilemjian: Excellent talks by leading pharma and biotech companies at BioTechX Europe

 

BioTechX cancer europe GenAI Innoplexus OncoDaily Oncology Partex switzerland Vrouyr Bilemjian
Special Coverage
Blog
Jan 20, 2025, 11:28
Fernanda Rivera's Journey as the first Mexican RadOnc Resident to receive the ASCO IDEA Award
Blog
Jan 20, 2025, 04:32
Bevacizumab and carboplatin-pemetrexed chemotherapy with/out atezolizumab for advanced pleural mesothelioma
Blog
Jan 20, 2025, 04:29
Katsuaki Maehara: Lung EGFR mutations catalog
Opinion
Jan 20, 2025, 04:25
Elisabetta Bonzano: The identification and validation of patient-specific vulnerabilities
Blog
Jan 20, 2025, 04:21
Robin Zon: Behind every diagnosis, test, approval/ disapproval and outcome is a patient and their family
Insight
Jan 20, 2025, 04:14
Laura Bukavina discusses a paper on BCG treatment for patients with urothelial carcinoma of the prostatic urethra
Insight
Jan 20, 2025, 04:00
FDA approved datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer
Career
Jan 20, 2025, 03:10
Lawrence “Larry” Deist Appointed to Board of Directors at Rally Foundation for Childhood Cancer Research
Blog
Jan 20, 2025, 02:54
Drew Moghanaki: A new medical oncology position at the VA Medical Center in Long Beach
Science
Jan 20, 2025, 02:44
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical HL
Science
Jan 20, 2025, 02:16
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer
Blog
Jan 20, 2025, 02:14
Akriti Jain: Grateful to present at Cleveland Clinic ASH review